{"id":11167,"date":"2018-07-27T21:46:58","date_gmt":"2018-07-27T21:46:58","guid":{"rendered":"https:\/\/clone.arsacs.com\/development-of-optimized-molecules-that-reverse-the-molecular-phenotype-of-arsacs-dr-michel-bouvier\/"},"modified":"2026-03-16T18:10:01","modified_gmt":"2026-03-16T22:10:01","slug":"development-of-optimized-molecules-that-reverse-the-molecular-phenotype-of-arsacs-dr-michel-bouvier-2","status":"publish","type":"post","link":"https:\/\/arsacs.com\/fr\/development-of-optimized-molecules-that-reverse-the-molecular-phenotype-of-arsacs-dr-michel-bouvier-2\/","title":{"rendered":"Development of Optimized Molecules That Reverse The Molecular Phenotype of ARSACS &#8211; Dr. Michel Bouvier"},"content":{"rendered":"The goal of this project is to develop small molecules that reverse the cellular phenotype of ARSACS into\na drug that would stop the progression of the disease and\/or lead to clinical improvement. The project is\na multidisciplinary collaboration between Dr Bernard Brais\u2019 (McGill Univ.) and Dr Michel Bouvier\u2019s (IRIC,\nInstitute of Researcher in Immunology and Cancer, Univ. of Montreal) laboratories with the participation\nof the High Throughput Screening (HTS) and Medicinal Chemistry core facilities at IRIC.\n\nDuration: One year\nGrant: $150,000\n\nContact\n\n<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/arsacs.com\/wp-content\/uploads\/2021\/02\/Michel_Bouvier-1-150x150-2.jpg\" alt=\"\" width=\"150\" height=\"150\" class=\"alignleft size-thumbnail wp-image-3353\">\n\nDr.Michel Bouvier, Institute for Research in Immunology and Cancer  (IRIC)\nIRIC | Universit\u00e9 de Montr\u00e9al C.P. 6128, succursale Centre-ville, Montr\u00e9al (Qu\u00e9bec) H3C 3J7\nTel: (514)-343-6319 ; Email: michel.bouvier@umontreal.ca","protected":false},"excerpt":{"rendered":"<p>The goal of this project is to develop small molecules that reverse the cellular phenotype of ARSACS into a drug that would stop the progression of the disease and\/or lead to clinical improvement. The project is a multidisciplinary collaboration between Dr Bernard Brais\u2019 (McGill Univ.) and Dr Michel Bouvier\u2019s (IRIC, Institute of Researcher in Immunology [&#8230;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26],"tags":[],"class_list":["post-11167","post","type-post","status-publish","format-standard","hentry","category-research-2018"],"_links":{"self":[{"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/posts\/11167","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/comments?post=11167"}],"version-history":[{"count":2,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/posts\/11167\/revisions"}],"predecessor-version":[{"id":24411,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/posts\/11167\/revisions\/24411"}],"wp:attachment":[{"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/media?parent=11167"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/categories?post=11167"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/arsacs.com\/fr\/wp-json\/wp\/v2\/tags?post=11167"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}